3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
8
Ovarian Neoplasms
8
Fallopian Tube Neoplasms
4
Lung Neoplasms
3
Sarcoma, Ewing
2
Neuroblastoma
2
Neoplasm Metastasis
2
Ganglioneuroblastoma
2
Central Nervous System Neoplasms
2
Uterine Cervical Neoplasms
1
SCLC
1
Rhabdoid Tumor
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Fallopian Tube Mucinous Adenocarcinoma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Endometrial Neoplasms
1
Choroid Plexus Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Interventions
venetoclax
6
ibrutinib
4
pirtobrutinib
2
Sirolimus
2
Rituximab
2
Mycophenolic Acid
2
Cyclosporine
2
Cyclophosphamide
2
zanubrutinib
1
pembrolizumab
1
loncastuximab tesirine
1
fludarabine phosphate
1
carfilzomib
1
acalabrutinib
1
Whole-Body Irradiation
1
Tacrolimus
1
Specimen Handling
1
Rifaximin
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Etoposide
1
Dexamethasone
1
Cyclosporins
1
Calcium Dobesilate
1
CT-P10
1
Busulfan
1
Biopsy
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Topotecan
×
30 days
×
Clear all
No trials found.